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Abstract
Reactive gliosis is a hallmark of brain pathology and the injury response, yet the extent to which astrocytes proliferate, and
whether this is central to astrogliosis is still controversial. We determined the fraction of mature astrocytes that proliferate in
a mouse stroke model using unbiased stereology as a function of distance from the infarct edge. Cumulatively 11.161.2% of
Aldh1l1
+ astrocytes within 400 mm in the cortical penumbra incorporate BrdU in the first week following stroke, while the
overall number of astrocytes does not change. The number of astrocytes proliferating fell sharply with distance with more
than half of all proliferating astrocytes found within 100 mm of the edge of the infarct. Despite extensive cell proliferation
primarily of microglia and neutrophils/monocytes in the week following stroke, few mature astrocytes re-enter cell cycle,
and these are concentrated close to the infarct boundary.
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Introduction
Astrogliosis is a hallmark of diseased CNS tissue [1]. This term
refers to progressive changes in gene expression and cellular
morphology, often including proliferation. However, data bearing
on the extent and importance of astrocyte proliferation in reactive
astrogliosis are inconsistent. Which gene expression changes are
required, and whether astrocyte activation encompasses more than
one activated phenotype, require further clarification. Reports
both of little cell division and some estimates as high as 50% leave
the contribution of astrocyte proliferation to reactive astrogliosis a
subject of debate [2–4]. Here we used unbiased stereology to
determine the extent of astrocyte proliferation as a function of
distance from the infarct in the penumbra following stroke.
More studies on astrocyte proliferation have been published in
brain stab wound injury than in stroke. Astrocytes accounted for
up to one-fifth of the dividing cells in traumatic brain injury, but
mitotic astrocytes represented only 2% of the total astrocyte
population [5–8]. Similar proportions were estimated by Janeczko
et al. [9,10] and Schiffer et al. [11,12] following brain injury.
Several investigators have suggested that astrocyte proliferation
contributes only a small number of cells [8,13–18], and one
quantitative study found no evidence of proliferation [19]. Despite
the suggestion in some studies that there is little proliferation,
studies with GFAP-TK mice suggest a robust proliferative
astrocyte response, and that this proliferation is important to scar
formation [3,4]. Another study which identified a high rate of
astrocyte proliferation was performed after stab wound injury and
assessed cells within 150 mm of the injury track [2].
A further important question is whether proliferation occurs in
immature cells or even progenitor cells which express GFAP in the
adult brain [20], rather than in mature astrocytes. The number of
astrocytes, as assessed by both glutamine synthetase (GS) and
S100b immunoreactivity in the cortical penumbra following stroke
does not increase strikingly over time, while GFAP and vimentin
expression do [21]. To assess proliferation of mature astrocytes,
compared to other cell types, we quantitated proliferation using
BrdU labeling in Aldh1l1-GFP mice to identify mature cortical
astrocytes [22] as well as double immunolabeling to identify other
cell types.
Materials and Methods
Ethics Statement
All experiments with mice were performed according to an
animal protocol (APLAC 9883) approved by the Stanford Animal
Care and Use Committee, and in keeping with the National
Institutes of Health guide.
Mice
Tg(Fthfd-EGFP)OFC789Gsat (Aldh1l1-GFP) mice. Transgenic
mice expressing EGFP from the Aldh1l1 locus in the Gsat BAC
were initially produced by Nathaniel Heintz and colleagues [23]
and were kindly provided by Ben Barres who obtained them from
MMRRC (http://www.mmrrc.org/strains/11015/011015.html).
Focal Cerebral Ischemia
Transient ischemia was induced using the suture occlusion
technique, as previously described [24]. Adult male mice 2565g
were anesthetized, and the left carotid artery bifurcation was
exposed. A 6–0 monofilament nylon suture (Doccol Co., Red-
lands, CA, USA) was inserted from the common carotid artery
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artery (MCA) at its origin. After 60 min the suture was removed
for reperfusion, the CCA ligated, and the wound closed. Sham-
operated animals underwent identical procedures as far as
isolation of the carotid bifurcation but without opening the artery
or suture insertion. Rectal temperature was maintained at
37uC60.5uC controlled by a Homeothermic blanket control unit
(Harvard Apparatus, Holliston, MA, USA). Temperature and
respiratory rate were monitored during the surgery.
Tissue Fixation and Immunohistochemistry
On day 3 and 7 after stroke or sham-operation mice were
sacrificed for analysis. Animals were deeply anesthetized with
isoflurane, and perfused through the left cardiac ventricle, first with
0.9%cold salineand thenwith4%paraformaldehydeinphosphate-
buffered saline (PBS; pH 7.4). Brains were removed and immersed
overnight at 4uC in the same fixative and then rinsed with 0.1 M
PBS. Coronal sections, 40 mm thick, were made with a Vibratome
(VT 1000 S; Leica Microsystems, Wetzlar, Germany).
Proliferation studies
Aldh1l1-GFP mice received three doses of BrdU (50 mg/kg in
saline intraperitoneally; B5002, Sigma-Aldrich, St. Louis, MO) on
day 2 and were sacrificed on day 3; or for cumulative proliferation,
animals received three BrdU injections per day on days 2–6, and
were sacrificed on day 7. Sections were processed for BrdU
immunohistochemistry followed by double labeling with glial and
neutrophil/monocytes markers. For BrdU immunostaining, sec-
tions were pretreated with 2 N HCL for 30 min at 37uC followed
by 3 washes in 0.1 M PBS then incubated with polyclonal sheep
anti-BrdU (1:50, ab1893, Abcam, UK) for 2 days. Sections were
then rinsed with 0.1 M PBS and incubated with Alexa 594 donkey
anti-sheep (1:500, Invitrogen) for 2 h. After 3 washes in PBS,
sections were incubated with primary antibody for glial fibrillary
acidic protein (GFAP, diluted 1:5, #22522, Immunostar, Hudson,
WI, USA), rabbit anti-S100b (diluted 1:200, Z0311, DAKO,
Carpinteria, CA), rat anti-CD68 (clone ED1, diluted 1:200,
MCA1957GA, Serotec, Raleigh, NC), rabbit anti-Iba1 (1:400;
019–19741, Wako Chemicals USA, Richmond, VA) or rabbit
anti-MPO (diluted 1:200, A0398, DAKO, Carpenteria, CA).
Sections were then incubated with respective secondary antibody,
washed 3 times in 0.1 M PBS, mounted, and coverslipped with
mounting medium (Vector Laboratories, CA). Representative
micrographs were photographed at 206 or 406 using a Zeiss
LSM 510 META inverted laser scanning confocal microscope
(Zeiss, Germany). Z-stacks of 8 planes with 1 mm spacing were
recorded in 6 min intervals. All counts were performed on coded
sections so the investigator was blinded to the treatment group.
Immunofluorescence for cleaved (active) caspase 3
For the detection of apoptosis in frozen tissue, sections were
pretreated with 10 mM citrate buffer pH 6.0 at 80uC for 45 min.
Sections were then cooled down for 15 min in the same buffer at
room temperature (RT), washed 3 times in 0.1 M PBS and
incubated with polyclonal rabbit anti-cleaved caspase 3 (diluted
1:10, AB3623, Millipore, Bedford, MA) for 2 days. Sections were
rinsed with 0.1 M PBS and incubated with Alexa 594 goat anti-
rabbit (diluted 1:500, Invitrogen) for 2 h at RT, mounted and
coverslipped with mounting medium (Vector Laboratories).
Morphometric analysis
Brains that showed a similar infarcted area were used for
morphometry to avoid the confound of differing extents of injury.
The border between normal appearing cells and infarcted tissue is
readily identified after 24 h [25] by the morphological appearance
of nuclei. The core was identified as the region in which the
majority of DAPI stained nuclei were shrunken, or the edge by
appearance of Aldh1l1 fluorescent astrocytes (Figure 1A) whereas
the penumbra was defined as the region of generally morpholog-
ically normal cells, 400–500 mm wide, surrounding the core. The
number of Aldh1l1, GFAP, CD68, Iba1, MPO, or caspase 3
immunoreactive cells and double labelled cells immunoreactive for
BrdU and cell type specific markers, was assessed in layer II-III of
the cortical penumbra and within a distance of 400 mm from the
border of the ischemic core of 3 mice for day 3 and 5 mice for day
7. Immunoreactive cells were estimated by the fractionator
dissector method and a total of 16 counting frames of
1006100 mm each/section were counted. Three sections/animal
(equally spaced between 21.70 to 22.18 mm relative to Bregma)
were analyzed, comprising about 25% of the cortical penumbra
using Image J software to analyze the micrographs.
Statistics
Data are expressed as mean 6 SEM. The differences between
groups were determined by t-test when only two groups were
compared; differences between multiple groups were determined
by one way analysis of variance followed by post hoc Tukey’s
multiple comparison test, using Graphpad Prism 5 (GraphPAD
Software for Science, San Diego, CA, USA). Differences were
considered statistically significant for p-values,0.05.
Results
Serial confocal pictures were taken in the border area of the
ischemic penumbra/ischemic core for unbiased stereological
image analysis to quantitate the response of Aldh1l1
+ astrocytes
to injury. Early proliferation was assessed by injecting BrdU on
day 2, and cumulative proliferation was determined by repetitive
BrdU injections from day 2–6 after MCAO (Figure 1B).
Proliferation is greater in the cortical penumbra on day 2, with
little BrdU labelling in the ischemic core (Figure 1C). By day 6 post
MCAO, this changes to pronounced proliferation in the core
(Figure 1C) with some ongoing proliferation in the penumbra
(Figures 1C,D). Cell counting was performed within 400 mm of the
IC/P border, but beyond the glial scar which develops at the IC/P
boundary. Proliferating cells consisted predominantly of morpho-
logically large and small round cells. The number of MPO
+ cells
rises dramatically from undetectable levels in the sham condition,
and CD68
+ and Iba1
+ cells were present at high density in the
penumbra on day 3 (Figure 1D). Representative low power
micrographs of immunostaining for Iba1, MPO, and CD68 in the
penumbra on days 3 and 7 are shown in Figure S2. The increased
number of activated microglia and monocytes on day 7, relative to
day 3, demonstrates an increased immunological and inflamma-
tory response bordering the lesion (Figure 1D). Double labeling for
BrdU and myeloperoxidase (MPO), a marker for polymorphonu-
clear neutrophils and monocytes, Iba1 for resting and activated
microglia/macrophages, and CD68 for activated microglia/
macrophages (Figures 2A–C) demonstrated that the large round
proliferating cells were MPO
+ neutrophils/monocytes, and
accounted for 44.566.1% and 31.761.1% of BrdU
+ cells on
days 2 and 2–6, respectively. The small proliferating cells were
microglia/macrophages, corresponding to 37.463.1% and
32.9.067.5% for Iba1
+ immunoreactive cells, 26.560.7% and
28.360.6% for CD68
+ cells, on days 2 and 2–6, respectively
(Figure 2D).
Limited Astrocyte Proliferation after Stroke
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+ astrocytes co-express GFAP (53.962.0% on day 3
within 400 um of the core) and S100b in the penumbra (Figure 3A
and Figure S1), and orthogonal views show that some GFAP/
Aldh1l1 double positive cells also label with BrdU (Figure 3B). The
total number of Aldh1l1
+ astrocytes was not significantly different
on post-stroke day 3 or 7 compared to sham (Figures 3C,D). This
was consistent with the small fraction of Aldh1l1 positive cells that
labeled for BrdU
+ (8.561.2% for day 2; 11.161.2% cumulatively
for days 2–6), and by the small percentage of BrdU
+ cells that were
also positive for Aldh1l1 (6.461.4% for day 2; 8.760.6% for days
2–6), suggesting that mature astrocytes do not proliferate
extensively after stroke, and that proliferation happens early.
The finding that about 10% of Aldh1l1
+ astrocytes incorporate
BrdU raises the question of whether this might be an
underestimate due to loss of astrocytes by apoptosis. To address
this question we stained sections for cleaved caspase 3 to assess the
number of apoptotic Aldh1l1
+ astrocytes on days 3 and 7 post
MCAO. A few apoptotic cells are found in the core on post-stroke
day 3, contrasting with greater numbers of caspase 3 immunore-
active cells in the penumbra, while on day 7 there continue to be
large numbers of apoptotic cells in the core, but few in the
Figure 1. Cellular proliferation assessed with BrdU. (A) Low
power micrographs show the edge of the core outlined by Aldh1l1
fluorescent astrocytes (green) present at the boundary visibly
separating the core from the surrounding tissue on days 3 and 7 after
ischemia; higher magnification of the areas indicated in the white boxes
are shown below the low power images. (B) To study the proliferative
response BrdU was injected 3 times/day on day 2 and animals were
sacrificed on day 3 to determine the early response. A second group
was injected 3 times/day from days 2–6 to analyze cumulative
proliferation over the week following stroke, with animals sacrificed
on day 7. (C) Panoramic views of sections immunostained for BrdU
show proliferation in both penumbra (P) and ischemic core (IC), with
somewhat stronger staining in penumbra on day 2, while the core
showed more labelled cells on days 2–6. (D) Morphometric analysis
Figure 2. Analysis of proliferating cells in the penumbra
identifies many inflammatory cells. Using different antibodies to
identify the cell types labelled with BrdU, reveals that most proliferating
cells are microglia/macrophages (A, C) and monocytes/neutrophils by
colocalization (B) of cell type markers with BrdU, and this was confirmed
by the morphometric analysis (D). N=3 animals for day 2, N=5 animals
for day 7. Scale Bar, 50 mm.
doi:10.1371/journal.pone.0027881.g002
shows the density of each cell type in the penumbra, demonstrating an
increased inflammatory reaction surrounding the core. Sham animals
were also analyzed for the number of each cell type on day 3 and 7, but
the numbers for each cell type did not change significantly, so only the
data for day 3 is shown. No MPO positive cells were detected in the
sham animals. Scale Bar, 50 mm.
doi:10.1371/journal.pone.0027881.g001
Limited Astrocyte Proliferation after Stroke
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11.462.1% of Aldh1l1
+ cells co-label with caspase 3 on day 3, and
4.460.6% on day 7 (Figure 4C) thus accounting for the overall
lack of change in numbers of Aldh1l1 cells, with apoptosis like
proliferation occurring early after the injury.
One hypothesis that could reconcile the divergent estimates of
astrocyte proliferation following injury is the concept that the
probability of astrocytes reentering the cell cycle is a function of
their distance from the injury. Because our stereological study used
100 mm square counting frames we were able to analyze the
number of BrdU
+ Aldh1l1
+ cells as a function of distance from the
edge of the infarct. When BrdU
+ Aldh1l1
+ cells are analyzed as a
fraction of all BrdU
+ cells the fraction falls rapidly with distance
from the core (Figure 5A). The percent of Aldh1l1
+ BrdU
+ cells
found in each 100 mm compared to the total number of Aldh1l1
+
BrdU
+ cells also fell rapidly with distance (Figure 5B), with about
60% of all BrdU labeled astrocytes within 100 mm of the core, and
about 80% within 200 mm. The maximum percent of Aldh1l1
cells that labeled was about 20% (Figure 5C) and this was seen
within 100 mm of the scar. Similar patterns are observed with
labeling on day 2 or days 2–6.
Discussion
Proliferation of mature astrocytes after stroke in the cortical
penumbra cumulatively over the first week was surprisingly
modest at 11.1%. This data reinforces the concept that mature
astrocytes do not widely resume proliferation after stroke.
Astrocytes at different distances from the edge of the ischemic
core undergo graded responses to injury, including graded degrees
of proliferation. There is clear evidence from others for astrocyte
proliferation at the scar boundary, while astrocytes further out
show reactive changes, but as shown quantitatively in this study,
largely without proliferation. Our analysis of proliferation with
distance from the injury allows us to reconcile several previously
disparate observations on the extent of astrocyte proliferation.
The highest levels of astrocytes proliferation have been observed
either in the scar or close to the edge of a stab wound [26,27].
Using cell counting methods, Alonso [26] showed that GFAP
+
cells at a distance of 200–250 mm from the wound accounted for
,20% and ,27% of all BrdU labelled cells on days 3 and 7,
respectively, following stab wound. More recently, Buffo et al. [2]
reported up to 50% of fate marked astrocytes within 150 mm of the
wound labelled with BrdU. This relatively high fraction is
consistent with proliferation largely restricted to the scar and
immediately next to the scar. In stroke there is a prior report of
extensive GFAP
+ astrocyte proliferation close to the infarct area in
the rat [20] but no unbiased quantitation was provided.
In contrast several other reports demonstrate low levels of
astrocyte proliferation after injury. A different study in stroke in
the rat determined that 10% of GFAP astrocytes within 250 mmo f
the core co-labeled with BrdU in the cortex [28], quite consistent
with our observations. Low levels of proliferation were also found
in a study in human ischemic stroke [29]. Using a genetic fate-
mapping and BrdU-labeling approach Burns et al. [30] showed
that cortical astrocytes cease proliferation before P10 and only
undergo nonproliferative gliosis (i.e., increased GFAP expression
Figure 3. Few Aldh1l1
+ astrocytes proliferate in the cortical
penumbra. (A) Triple labelling reveals that most astrocytes in the
cortical penumbra label for GFAP, Aldh1l1 and S100b. (B) Orthogonal
view of a mature astrocyte co-expressing Aldh1l1, BrdU and GFAP in the
cortical penumbra. (C) The number of Aldh1l1
+ astrocytes assessed in
layers II–III of the cortical penumbra does not change over the first
week post-injury, or compared to sham animals. (D) Illustrative confocal
micrographs show increased prominence of Aldh1l1 positive cells with
cellular hypertrophy, but no change in overall number. Scale Bar,
50 mm.
doi:10.1371/journal.pone.0027881.g003
Figure 4. Detection of apoptotic cells in the penumbra. (A)
Apoptotic cells identified by staining for cleaved caspase 3 show few
apoptotic cells in the core and some in the penumbra on day 3,
contrasting with a striking increase in apoptotic cells in the core on day
7. (B) Quantitation of apoptotic cells in the penumbra on days 3 and 7
after injury. (C) A small percent of Aldh1l1 cells are also apoptotic as
assessed by caspase 3 activation. The number significantly decreases
between days 3 and 7. IC=ischemic core; P=penumbra. N=3 mice for
day 2, N=5 mice for day 7. Scale Bar, 50 mm.
doi:10.1371/journal.pone.0027881.g004
Limited Astrocyte Proliferation after Stroke
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though they detected proliferation of NG2 positive cells. Similarly,
Dihne et al. [31] concluded that the unchanged density of
astrocytes in striatum in the days following excitotoxic CNS injury
suggests increased GFAP-reactivity without proliferation.
We observe the highest level of proliferation closest to the edge
of the infarct, which falls rapidly within 200 mm. The average
exclusive territory or domain size occupied by a single hippocam-
pal astrocyte is in the range of 24,000–66,000 mm
3 [32,33], and
similar observations about the domain structure of astrocytes have
been made in cortex [34]. This corresponds to a linear dimension
in the range of 50 to .100 mm for the domain of a single
astrocyte, suggesting that the astrocytes that undergo proliferation
either have the infarct directly within their territory, or border on
it. This fits nicely with earlier observations that there is significant
proliferation of astrocytes involved in scar formation [2,4,27] and
suggests that the extent to which astrocytes experience destruction
of their exclusive territory or domain is a key determinant of
whether they undergo proliferation. It allows us to reconcile some
of the widely different estimates of astrocyte proliferation in the
literature based on the distance from the injury where the
assessment was performed. Our results fit with a broader
understanding of the graded response of astrocytes to injury. This
encompasses proliferation to form the scar, an intermediate
activation phenotype in which some astrocytes may undergo
proliferation and in which there may be limited disruption of
domain structure, and finally a more distal activated astrocyte
population in which there is no proliferation, no loss of domain
structure, and activation is indicated only by changes in gene
expression including increased expression of GFAP and vimentin
[4].
A smaller percentage of astrocytes positive for Aldh1l1 undergo
apoptosis on day 7 than on day 3 after injury, with the overall
extent similar to that observed for proliferation, and consistent
with the overall lack of change in numbers of astrocytes. Other cell
types, namely microglia, monocytes, and progenitors, have been
shown to undergo apoptosis after stroke [35] and readily account
for the non-astrocytic apoptotic cells seen.
The findings reported here provide detailed quantitation of cell
proliferation following focal ischemia in the mouse, as a function of
distance from the scar. It is likely that the range of astrocyte
response to other injuries also falls along the continuum discussed
here between scar forming astrocytes exhibiting relatively high
levels of proliferation to astrocytes that do not proliferate at all, but
do show gene expression and morphological changes indicative of
activation. Thus following stroke, astrocytes in the penumbra
undergo limited proliferation and apoptosis, soon after injury, with
a strong spatial gradient. Most astrocyte proliferation occurs
within 200 mm of the edge of the infarct.
Supporting Information
Figure S1 A higher power view of the border on day 7
shows astrocytes extending their processes into the edge
of the core, with extensive but not complete colocaliza-
tion of Aldh1l1
+ (green channel) with GFAP (blue
channel) and S100b (red channel). Scale bar, 50 mm. GFAP
and S100b identified by immunostaining.
(TIF)
Figure S2 Low power micrographs showing represen-
tative staining for Iba 1, MPO, and CD68 in the
penumbra on days 3 and 7. Scale bar, 50 mm.
(TIF)
Figure 5. Astrocyte proliferation as a function of distance from
the infarct core. BrdU labelling on day 2 or 2–6 cumulatively shows a
small percentage of mature Aldh1l1
+ astrocytes proliferate after MCAO
within 400 mm of the ischemic core. Stereological analysis of astrocyte
proliferation as a function of distance shows that Aldh1l1
+ cells mainly
co-express BrdU in the first 200 mm from the infarct area; the number
decreases dramatically with distance. The fraction of proliferating
astrocytes compared to all proliferating cells in the penumbra is low (A),
and the fraction of proliferating astrocytes present falls rapidly with
distance (B), and the fraction of all astrocytes present that proliferate is
highest close to the core (C).
doi:10.1371/journal.pone.0027881.g005
Limited Astrocyte Proliferation after Stroke
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